How to Make DMT in Australia: Legal Realities, Plant Sources, and Scientific Facts
The search for how to make DMT in Australia often stems from curiosity about this powerful psychedelic compound. However, the answer must begin with the most serious legal warning. Making DMT in Australia constitutes manufacturing a prohibited drug, which is a serious criminal offence. DMT is classified as a Schedule 9 prohibited substance in Australia, making it illegal in all states and territories. The production process—whether through plant extraction or chemical synthesis—constitutes “manufacture,” which carries far more severe penalties than simple possession. This guide examines the legal consequences, Australia’s native plant sources, and the scientific reality of DMT synthesis.
The Legal Reality: Serious Consequences of Manufacturing DMT
First and foremost, you must understand a core fact. DMT is a Schedule 9 prohibited substance, and possession, use, manufacture, supply, importation, or exportation are all illegal. In Australian law, the definition of “manufacture” is very broad. A Western Australian appeals case established an important principle: extracting liquid DMT from plant material, even before purification into powder or paste, can be deemed “manufacturing” complete, because the liquid “can be ingested or injected.”
Penalties escalate dramatically by quantity in each state. In New South Wales, the maximum penalty for possession of DMT is 2 years imprisonment and/or a $2,200 fine. Supplying 0.8 grams (small quantity) carries a $5,500 fine and/or 2 years imprisonment. Supplying 0.5 kg (commercial quantity) carries a $385,000 fine and/or 20 years imprisonment. 2 kg (large commercial quantity) carries a maximum penalty of life imprisonment. At the federal level, importing DMT requires both an import licence and an import permit. Unauthorised importation also constitutes a serious offence.
Real cases demonstrate the intensity of enforcement. Since the first DMT extraction lab was discovered in Western Australia in 2008, detection rates have continued to rise. These labs are now the most common type of clandestine laboratory in WA. These labs typically involve extracting DMT from local Acacia bark using rudimentary equipment.
Australia’s Native Plant Sources: Acacia (Wattle)
Australia’s native Acacia genus (commonly known as wattle) does contain DMT. Western Australia is the diversity centre for Acacia, with 894 natural species. A 2026 WA pilot study screened phyllodes from 148 Acacia species and found some contained DMT and other tryptamines. A separate 2024 study screened 104 plant samples from 79 Acacia species.
Some widely cited DMT-containing species include Acacia maidenii (bark contains approximately 0.6% alkaloids, about two-thirds of which is DMT) and Acacia phlebophylla (leaf contains approximately 0.3% DMT). However, DMT content in Acacia is only 0.5% to 1.5%. This means extracting even a small amount of DMT requires processing large quantities of plant material.
Dr Kelly Shepherd from the WA Herbarium points out that ringbarking trees kills them. “From a conservation angle, ringbarking trees kills them. Even before you get to extracting an A-class drug, damaging native flora is an offence in itself,” she explains. A harm reduction leaflet also warns that many Acacia species are protected by law, and collecting any plant material from state or national parks is illegal and may be treated as trespassing, theft, vandalism, and intent to manufacture.
The Reality of Extraction: Why “Simple” Does Not Mean Feasible
Erowid hosts a detailed first-hand extraction account describing the process of extracting DMT from Acacia maidenii. The author soaked bark in methanol, then went through filtering, evaporation, acid treatment, basification, and solvent extraction, finally obtaining about one gram of pale yellow liquid that crystallised into needles upon standing. However, the entire process is labour-intensive, uses dangerous chemicals, and yields very little. The author described the smoking experience as “extremely intense” with “unpleasant smoke.”
More critically, chemical solvents themselves are regulated. Methanol, dichloromethane, and other solvents used for extraction are not freely purchasable. Furthermore, the strong acids and bases used in the process pose serious chemical burn and fire risks.
Biosynthesis: How Plants Make DMT
From a scientific perspective, DMT synthesis within plants is an enzyme-catalysed process. The biosynthetic pathway of DMT is part of the L-tryptophan biochemical cascade and can be divided into two steps. First, aromatic L-amino acid decarboxylase (AADC) catalyses the decarboxylation of tryptophan to tryptamine. Subsequently, indolethylamine-N-methyltransferase (INMT) uses S-adenosyl-L-methionine (SAM) as a methyl donor to perform double methylation of tryptamine.
A 2023 theoretical study revealed that the second methylation is the rate-limiting step, with an energy barrier approximately 60 kJ/mol higher than the first methylation. This research confirmed the key role of INMT in DMT synthesis. However, understanding the biosynthetic mechanism does not mean it can be replicated at home. This requires professional enzymological knowledge and laboratory conditions, making it just as complex and dangerous as solvent-based extraction.
Legitimate Alternative Pathways: Clinical Research and Education
In Australia, the only legal pathway to access DMT is participation in approved clinical trials. Australian clinical research is advancing. Dr Daniel Perkins’ team at the University of Melbourne developed a DMT formulation derived from Australian Acacia, prepared in CSIRO facilities rather than “dangerous garage labs.” The formulation underwent a first-in-human clinical trial with nine healthy volunteers, and participants reported effects that “exceeded prior published psilocybin and LSD results.” However, Dr Perkins notes that his team has moved to synthetic DMT, because “Acacia contains only 0.5-1.5% DMT,” making botanical products difficult to scale for pharmaceutical production.
Swinburne University of Technology also received $1.97 million from the Medical Research Future Fund to conduct a DMT-assisted psychotherapy trial for adults with alcohol use disorder and/or major depressive disorder.
For those seeking legal knowledge about DMT, educational lectures provide a safe knowledge pathway. Ethnobotanist Dr Liam Engel conducts psychoactive plant sessions in New South Wales covering DMT and other natural psychedelics. These sessions focus on harm reduction and education rather than consumption.
Conclusion
The question of how to make DMT in Australia has a clear and unambiguous answer. Making DMT is a criminal offence, constituting “manufacturing a prohibited drug.” Case law in Western Australia has confirmed that even liquid extracts can constitute manufacturing. Australian Acacia does contain DMT, but at very low concentrations (0.5-1.5%). Extraction requires large amounts of plant material and involves dangerous chemicals. The biosynthetic pathway within plants is driven by complex enzyme systems that cannot be replicated at home.
For those seeking DMT’s therapeutic potential, clinical trials are the only legitimate pathway. Research at the University of Melbourne has shown that DMT derived from Australian Acacia can be safely used in controlled research settings. The wisest course involves remaining informed about evolving clinical research, supporting evidence-based policy reform, and prioritising safety and legality above all else.